David J. Wambeke

Chief Business Officer, DiaMedica Therapeutics Inc.

Companies

NEUROONE MEDICAL TECHNOLOGIES CorpChief Business Officer Mar 3, 2026 to now¹
DiaMedica Therapeutics Inc.Chief Business Officer Apr 11, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

DiaMedica Therapeutics Inc. DMAC527,114 shares³$4.2M at $7.96Jun 3, 2025
NEUROONE MEDICAL TECHNOLOGIES Corp NMTC199,999 shares⁴$202.0K at $1.01Aug 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 27, 2026Bought 33,333 shares at $2.01 of NEUROONE MEDICAL TECHNOLOGIES Corp⁴
Mar 1, 2026Bought 1,000,000 shares at $0.67 of NEUROONE MEDICAL TECHNOLOGIES Corp⁵
Nov 16, 2023Bought 20,000 shares at $2.46 of DiaMedica Therapeutics Inc.⁶
Jun 23, 2023Bought 38,364 shares at $3.91 of DiaMedica Therapeutics Inc.⁷
Apr 10, 2023Bought 468,750 shares at $1.60 of DiaMedica Therapeutics Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNEUROONE MEDICAL TECHNOLOGIES Corp, Chief Business Officer
2
SEC EDGARDiaMedica Therapeutics Inc., Chief Business Officer
3
SEC EDGARDiaMedica Therapeutics Inc. shares after the filing of Jun 3, 2025
4
SEC EDGARNEUROONE MEDICAL TECHNOLOGIES Corp shares after the filing of Aug 27, 2026
5
SEC EDGARForm 4 filed Mar 3, 2026
6
SEC EDGARForm 4 filed Nov 16, 2023
7
SEC EDGARForm 4 filed Jun 26, 2023
8
SEC EDGARForm 4 filed Apr 11, 2023